Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first1,881 to 1,900 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| PSG2 pregnancy specific beta-1-glycoprotein 2 | 5670 HGNC:9519 | 1 | 29 | 0 | 0 | 956 | 3,544 |
| LPAR2 lysophosphatidic acid receptor 2 | 9170 HGNC:3168 | 1 | 0 | 0 | 0 | 2,528 | 3,539 |
| SLC6A2 solute carrier family 6 member 2 | 6530 HGNC:11048 | 1 | 46 | 112 | 1,737 | 2,396 | 3,539 |
| VASP vasodilator stimulated phosphoprotein | 7408 HGNC:12652 | 1 | 58 | 0 | 0 | 2,029 | 3,538 |
| TNFRSF14 TNF receptor superfamily member 14 | 8764 HGNC:11912 | 1 | 221 | 0 | 0 | 1,851 | 3,537 |
| C1S complement C1s | 716 HGNC:1247 | 1 | 141 | 2 | 9 | 1,805 | 3,534 |
| GALNS galactosamine (N-acetyl)-6-sulfatase | 2588 HGNC:4122 | 1 | 89 | 0 | 0 | 2,525 | 3,532 |
| ASS1 argininosuccinate synthase 1 | 445 HGNC:758 | 1 | 122 | 0 | 0 | 1,983 | 3,531 |
| MIRLET7C microRNA let-7c | 406885 HGNC:31480 | 0 | 0 | 0 | 0 | 1,492 | 3,526 |
| NCOA3 nuclear receptor coactivator 3 | 8202 HGNC:7670 | 1 | 28 | 0 | 0 | 2,249 | 3,524 |
| MIR100 microRNA 100 | 406892 HGNC:31487 | 0 | 0 | 0 | 0 | 1,268 | 3,523 |
| CAV2 caveolin 2 | 858 HGNC:1528 | 1 | 75 | 0 | 0 | 2,540 | 3,520 |
| SLC16A3 solute carrier family 16 member 3 | 9123 HGNC:10924 | 1 | 120 | 0 | 0 | 1,561 | 3,520 |
| APOL1 apolipoprotein L1 | 8542 HGNC:618 | 1 | 105 | 0 | 0 | 2,721 | 3,519 |
| MAD2L1 mitotic arrest deficient 2 like 1 | 4085 HGNC:6763 | 1 | 54 | 0 | 0 | 1,607 | 3,516 |
| SMN2 survival of motor neuron 2, centromeric | 6607 HGNC:11118 | 1 | 140 | 4 | 54 | 1,484 | 3,510 |
| POU2F1 POU class 2 homeobox 1 | 5451 HGNC:9212 | 1 | 42 | 0 | 0 | 2,324 | 3,509 |
| TERF2 telomeric repeat binding factor 2 | 7014 HGNC:11729 | 1 | 13 | 0 | 0 | 2,127 | 3,508 |
| FMOD fibromodulin | 2331 HGNC:3774 | 1 | 49 | 0 | 0 | 1,493 | 3,504 |
| DDB1 damage specific DNA binding protein 1 | 1642 HGNC:2717 | 1 | 31 | 6 | 1,695 | 2,290 | 3,503 |
Code
curl "https://conductscience.org/api/genes/v1?page=95"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=95
{
"data": {
"total": 193990,
"results": [
{
"id": "5670",
"title": "PSG2: pregnancy specific beta-1-glycoprotein 2",
"summary": "NCBI Gene 5670. 1 protein, 29 patents, 0 drugs, 0 trials, 956 NIH grants and 3,544 papers.",
"record": "/library/genes/5670",
"gene_id": 5670,
"symbol": "PSG2",
"name": "pregnancy specific beta-1-glycoprotein 2",
"hgnc_id": "HGNC:9519",
"counts": {
"proteins": 1,
"patents": 29,
"drugs": 0,
"trials": 0,
"grants": 956,
"papers": 3544
}
},
{
"id": "9170",
"title": "LPAR2: lysophosphatidic acid receptor 2",
"summary": "NCBI Gene 9170. 1 protein, 0 patents, 0 drugs, 0 trials, 2,528 NIH grants and 3,539 papers.",
"record": "/library/genes/9170",
"gene_id": 9170,
"symbol": "LPAR2",
"name": "lysophosphatidic acid receptor 2",
"hgnc_id": "HGNC:3168",
"counts": {
"proteins": 1,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 2528,
"papers": 3539
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=96",
"request_id": "DQFO3SOcaz9E8G4f"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant